查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球骨骼生长刺激市场：按产品（设备（外部骨骼生长刺激、富含血小板血浆）、应用（脊柱融合、口腔和颌面外科）、用户预测到2027
市场调查报告书
商品编码
1138438

全球骨骼生长刺激市场：按产品（设备（外部骨骼生长刺激、富含血小板血浆）、应用（脊柱融合、口腔和颌面外科）、用户预测到2027

Bone Growth Stimulator Market by Product(Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application(Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End Users(Hospital, Ambulatory surgical centers) - Global Forecast -2027
出版日期: | 出版商: MarketsandMarkets | 英文 211 Pages | 订单完成后即时交付

价格
简介目录

全球骨骼生长刺激市场规模将从 2022 年的 14 亿美元估计到 2027 年达到 18 亿美元，预测期内 2022-2027 年的复合年增长率为 5.9%预计。

脊柱融合手术对骨骼生长刺激的需求不断增加，以及对非手术和非侵入性治疗的偏好不断增加，这些都推动了市场增长。

“从骨骼生长刺激市场的产品来看，骨骼生长刺激设备部分将在预测期内占最高增长率”

按产品划分，全球骨生长刺激设备市场分为外部骨生长刺激、超声波骨生长刺激和植入式骨生长刺激。 2021年，外部骨骼生长刺激部分将在全球骨骼生长刺激市场中占据最大份额。此外，预计该细分市场在预测期内将呈现最高的增长率。这一细分市场的最大份额可归因于外部设备相对于内部/植入设备的优势，后者更便宜、无创且不需要手术进行植入和移除，预计将推动市场增长。

“脊柱融合段的复合年增长率最高”

按应用，全球骨生长刺激市场细分为脊柱融合、延迟癒合和难治性骨折、口腔颌面外科及其他应用。 2021年，脊柱融合领域在骨骼生长刺激市场中占据最大份额。支持增长的因素是人口老龄化和脊柱手术的增加。

“预计亚太市场将在预测期内以最高复合年增长率增长”

骨骼生长刺激市场细分为北美、欧洲、亚太地区、拉丁美洲、中东和非洲。由于人口老龄化、亚太新兴国家的经济快速增长以及脊柱外科手术的增加，预计亚太地区骨骼生长刺激市场将在预测期内实现高速增长。

内容

第一章介绍

第二章研究方法

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 市场机会
    • 市场问题
  • 价格分析
  • 价值链分析
  • 供应链分析
  • 波特五力分析
  • 生态系统分析
  • 监管分析
  • 专利分析
  • 影响客户业务的趋势/中断
  • 主要会议和活动
  • 技术分析
  • 主要利益相关者和采购标准
  • 贸易分析

第 6 章骨骼生长刺激市场：按产品分类

  • 简介
  • 骨骼生长刺激装置
  • 骨形态发生蛋白
  • 富含血小板的血浆

第 7 章。骨骼生长刺激市场：按应用分类

  • 简介
  • 脊柱融合手术
  • 迟发性癒合骨折/难治性骨折
  • 口腔颌面外科
  • 其他

第 8 章。骨骼生长刺激市场：按最终用户分类

  • 简介
  • 医院/门诊手术中心
  • 居家护理
  • 学术和研究机构

第 9 章。骨骼生长刺激市场：按地区划分

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中东和非洲

第 10 章竞争格局

  • 概览
  • 大公司/有影响力的公司采用的战略
  • 主要市场公司的收入份额分析
  • 市场份额分析
  • 竞争领导力映射
  • 初创公司/中小企业公司评估矩阵
  • 骨生长刺激市场主要参与者的足迹分析
  • 竞争场景

第 11 章公司简介

  • 主要公司
    • ORTHOFIX MEDICAL INC.
    • DEPUY SYNTHES
    • STRYKER
    • BIOVENTUS LLC
    • MEDTRONIC PLC
    • ENOVIS CORPORATION（FORMERLY COLFAX）
    • ZIMVIE INC.（SUBSIDIARY OF ZIMMER BIOMET）
    • ARTHREX, INC.
    • TERUMO CORPORATION
    • OSSATEC BENELUX LTD.
    • ISTO BIOLOGICS
    • EMBER THERAPEUTICS, INC.
    • REGEN LAB SA
    • ALTIS BIOLOGICS（PTY）LTD.
    • ITO CO., LTD.
  • 其他企业
    • ELIZUR CORPORATION
    • BTT HEALTH GMBH
    • STIMULATE HEALTH
    • VQ ORTHOCARE
    • KINEX MEDICAL COMPANY, LLC

第12章 附录

简介目录
Product Code: MD 5234

The global bone growth stimulators market is valued at an estimated USD 1.8 billion by 2027 from an estimated USD 1.4 billion in 2022, at a CAGR of 5.9% from 2022 to 2027 during forecast period.The growing demand for bone growth stimulators in spinal fusion surgeries applications; the rising preference for non-surgical and non invasive treatment.

"The bone growth stimulators devices segment accounted for the highest growth rate in the bone growth stimulation devices market, by product, during the forecast period."

Based on product, the global bone growth stimulation devices market is segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators and Implanted Bone Growth Stimulators. In 2021, the external Bone Growth Stimulators segment accounted for the largest share of the global bone growth stimulators market. This segment is also expected to grow at the highest rate during the forecast period. The largest share of this segment can be attributed to the advantages of external devices over internal/implanted devices, these are less expensive, noninvasive, and do not require surgeries for implantation and removal which will drive the market growth.

"Spinal fusion surgeries segment accounted for the highest CAGR"

On the basis of application, the global bone growth stimulators market is segmented into - spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. In 2021, the spinal fusion surgeries segment accounted for the largest share of the bone growth stimulators market. Factors supporting the growth increasing growing geriatric population and the rising number of spine procedures.

"The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period."

The bone growth stimulators market is segmented into - North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. The bone growth stimulators market in several Asia-Pacific countries is expected to witness high growth during the forecast period owing to the aging population, rapid economic growth in emerging APAC countries and rising volume of spine procedures.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: Director-level-14%, C-level-10%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

Lists of Companies Profiled in the Report:

  • Orthofix Medical Inc. (US)
  • Enovis Coperation (US)
  • ZimVie (US)
  • Bioventus LLC (US)
  • Medtronic plc (Ireland)
  • Stryker (US)
  • DePuy Synthes (US)
  • Arthrex, Inc. (US)
  • Isto Biologics (US)
  • Terumo Corporation (Japan)
  • Ember Therapeutics, Inc. (US)
  • Ossatec Benelux Ltd. (Netherlands)
  • Altis Biologics (Pty) Ltd. (South Africa)
  • Regen Lab SA (Switzerland),
  • ITO Co., Ltd. (Japan)
  • Elizur Corporation (US)
  • BTT Health GmbH (Germany)
  • Stimulate Health (Canada)
  • VQ OrthoCare (US)
  • Kinex Medical Company, LLC (US)

Research Coverage

This report studies the bone growth stimulators market based on the product, application, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall bone growth stimulators market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.1 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • FIGURE 9 ASSUMPTIONS FOR STUDY
    • TABLE 1 INDICATORS AND ASSUMPTIONS
  • 2.5 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BONE GROWTH STIMULATORS MARKET

4 PREMIUM INSIGHTS

  • 4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
    • FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 15 BONE GROWTH STIMULATION DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
  • 4.3 GEOGRAPHIC SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
    • FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 BONE GROWTH STIMULATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
      • 5.2.1.2 Increasing target patient population
      • 5.2.1.3 Rising number of sports and accident-related orthopedic injuries
    • FIGURE 18 US: INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES (2021)
      • 5.2.1.4 Rising geriatric population
    • TABLE 2 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Limited medical reimbursement for bone stimulation products
      • 5.2.2.2 High treatment costs associated with BMP and PRP products
      • 5.2.2.3 Limited clinical evidence to support therapeutic efficacy of bone growth stimulators
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Increasing use of PRP in other applications
      • 5.2.3.3 Rising number of hospitals and surgical centers
    • TABLE 3 NUMBER OF ASCS AND OPERATING ROOMS, 2015-2020
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Lack of access to diagnostics
      • 5.2.4.2 Side effects associated with BMP-based orthopedic treatment
    • TABLE 4 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
    • TABLE 5 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
  • 5.3 PRICING ANALYSIS
    • TABLE 6 PRICE RANGE FOR BONE GROWTH STIMULATORS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.5 SUPPLY CHAIN ANALYSIS
    • 5.5.1 PROMINENT COMPANIES
    • 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.5.3 END USERS
    • FIGURE 20 BONE GROWTH STIMULATORS: SUPPLY CHAIN ANALYSIS
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 OVERVIEW
    • TABLE 7 BONE GROWTH STIMULATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.2 THREAT OF NEW ENTRANTS
    • 5.6.3 THREAT OF SUBSTITUTES
    • 5.6.4 BARGAINING POWER OF SUPPLIERS
    • 5.6.5 BARGAINING POWER OF BUYERS
    • 5.6.6 DEGREE OF COMPETITION
  • 5.7 ECOSYSTEM ANALYSIS
    • TABLE 8 BONE GROWTH STIMULATORS: ROLE IN ECOSYSTEM
    • FIGURE 21 KEY PLAYERS IN BONE GROWTH STIMULATORS ECOSYSTEM
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
    • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.8.1.2 Canada
    • TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.2 EUROPE
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 Japan
    • TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.8.3.2 China
    • TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.3.3 India
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT TRENDS FOR BONE GROWTH STIMULATORS
    • FIGURE 22 PATENT ANALYSIS (JANUARY 2013-SEPTEMBER 2022)
    • 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 23 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BONE GROWTH STIMULATOR PATENTS, JANUARY 2013-SEPTEMBER 2022
  • 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR BONE GROWTH STIMULATOR MANUFACTURERS
    • FIGURE 24 REVENUE SHIFT FOR BONE GROWTH STIMULATORS
  • 5.11 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 14 BONE GROWTH STIMULATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS
    • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS (%)
    • 5.13.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
    • TABLE 16 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
  • 5.14 TRADE ANALYSIS
    • 5.14.1 TRADE ANALYSIS FOR BONE GROWTH STIMULATORS
    • TABLE 17 IMPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 18 EXPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017-2021 (USD MILLION)

6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 19 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 BONE GROWTH STIMULATION DEVICES
    • TABLE 20 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 21 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.1 EXTERNAL BONE GROWTH STIMULATORS
    • TABLE 22 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 23 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.1.1 Pulsed electromagnetic field devices
        • 6.2.1.1.1 Pulsed electromagnetic field devices to witness highest growth in external bone growth stimulators market
    • TABLE 24 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.1.2 Combined magnetic field devices
        • 6.2.1.2.1 Combined magnetic field devices portable, battery-powered, and noninvasive
    • TABLE 25 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.1.3 Capacitive coupling devices
        • 6.2.1.3.1 Need for frequent battery replacement or recharge-disadvantage associated with CC devices
    • TABLE 26 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
      • 6.2.2.1 Used in treatment of nonunion bone fractures and failed arthrodesis
    • TABLE 27 HCPCS CODE
    • TABLE 28 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.3 IMPLANTED BONE GROWTH STIMULATORS
      • 6.2.3.1 Implanted bone growth stimulators provide constant stimulation of bone directly at fracture site
    • TABLE 29 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 BONE MORPHOGENETIC PROTEINS
    • 6.3.1 SAFE AND EFFECTIVE ALTERNATIVES TO BONE GRAFTS
    • TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 PLATELET-RICH PLASMA
    • 6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET
    • TABLE 31 PLATELET-RICH PLASMA MARKET, BY REGION, 2020-2027 (USD MILLION)

7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 32 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 7.2 SPINAL FUSION SURGERIES
    • 7.2.1 SPINAL FUSION SURGERIES TO DOMINATE BONE GROWTH STIMULATORS MARKET
    • TABLE 33 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 DELAYED UNION AND NONUNION BONE FRACTURES
    • 7.3.1 INCREASING NUMBER OF DELAYED UNION AND NONUNION BONE FRACTURES TO INCREASE DEMAND FOR BONE GROWTH STIMULATORS
    • TABLE 34 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 ORAL AND MAXILLOFACIAL SURGERIES
    • 7.4.1 BMPS USED IN ORAL AND MAXILLOFACIAL SURGERIES TO FORM BASE FOR DENTAL IMPLANTS
    • TABLE 35 BONE GROWTH STIMULATORS MARKET FOR ORAL AND MAXILLOFACIAL SURGERIES, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 OTHER APPLICATIONS
    • TABLE 36 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

8 BONE GROWTH STIMULATORS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 37 BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
    • 8.2.1 LARGEST AND FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
    • TABLE 38 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS AND ASCS, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 HOME CARE SETTINGS
    • 8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
    • TABLE 39 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 ACADEMIC AND RESEARCH INSTITUTES
    • 8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO DRIVE MARKET
    • TABLE 40 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2020-2027 (USD MILLION)

9 BONE GROWTH STIMULATORS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 41 BONE GROWTH STIMULATORS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 High burden of sports-related injuries to drive market
    • TABLE 48 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 49 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 52 US: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Market growth driven by rising incidence of bone-related diseases
    • TABLE 53 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 54 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 55 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 60 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Largest market for bone growth stimulators in Europe
    • FIGURE 28 GERMANY: POPULATION AGED 65 AND ABOVE, 2015-2021 (MILLION)
    • TABLE 64 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 65 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 66 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 GERMANY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 68 GERMANY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Increasing funding by public and private organizations to drive market
    • TABLE 69 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 70 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 UK: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 73 UK: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising prevalence of diabetes to support market growth
    • TABLE 74 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 75 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 76 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 77 FRANCE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 78 FRANCE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market
    • TABLE 79 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 80 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 82 ITALY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 83 ITALY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
    • TABLE 84 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 85 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 SPAIN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 88 SPAIN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 89 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 90 REST OF EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 91 REST OF EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 93 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
    • TABLE 94 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan dominates Asia Pacific bone growth stimulators market
    • TABLE 100 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 101 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 JAPAN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 104 JAPAN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive market
    • TABLE 105 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 106 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 108 CHINA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 109 CHINA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Growing number of orthopedic surgeries to support market growth
    • TABLE 110 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 111 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 INDIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 114 INDIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Availability of grants for development of advanced treatments to support market growth
    • TABLE 115 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 116 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 119 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Supportive government initiatives positively impact market growth
    • TABLE 120 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 121 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 124 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC
    • TABLE 125 GERIATRIC POPULATION, BY COUNTRY, 2015-2021
    • TABLE 126 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 127 REST OF ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 REST OF ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 130 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 131 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 132 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 133 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 136 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Modernization of healthcare facilities to drive market
    • TABLE 137 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 138 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 141 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market
    • TABLE 142 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 143 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 MEXICO: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 146 MEXICO: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 147 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 148 REST OF LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 REST OF LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 151 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF BONE GROWTH STIMULATORS
    • TABLE 152 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 153 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 MIDDLE EAST AND AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 156 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
    • TABLE 157 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BONE GROWTH STIMULATORS MARKET
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • TABLE 158 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
  • 10.5 COMPETITIVE LEADERSHIP MAPPING
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PARTICIPANTS
    • 10.5.4 PERVASIVE PLAYERS
    • FIGURE 31 BONE GROWTH STIMULATORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
  • 10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 32 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
  • 10.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
    • 10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
    • TABLE 159 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 160 REGIONAL FOOTPRINT OF COMPANIES
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • TABLE 161 KEY PRODUCT LAUNCHES, JANUARY 2019-AUGUST 2022
    • 10.8.2 DEALS
    • TABLE 162 KEY DEALS, JANUARY 2019-AUGUST 2022
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 163 OTHER KEY DEVELOPMENTS, JANUARY 2019-AUGUST 2022

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)**
    • 11.1.1 ORTHOFIX MEDICAL INC.
    • TABLE 164 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW
    • FIGURE 33 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2021)
    • 11.1.2 DEPUY SYNTHES
    • TABLE 165 DEPUY SYNTHES: BUSINESS OVERVIEW
    • FIGURE 34 DEPUY SYNTHES: COMPANY SNAPSHOT (2021)
    • 11.1.3 STRYKER
    • TABLE 166 STRYKER: BUSINESS OVERVIEW
    • FIGURE 35 STRYKER: COMPANY SNAPSHOT (2021)
    • 11.1.4 BIOVENTUS LLC
    • TABLE 167 BIOVENTUS LLC: BUSINESS OVERVIEW
    • FIGURE 36 BIOVENTUS LLC: COMPANY SNAPSHOT (2021)
    • 11.1.5 MEDTRONIC PLC
    • TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
    • 11.1.6 ENOVIS CORPORATION (FORMERLY COLFAX)
    • TABLE 169 ENOVIS CORPORATION (FORMERLY COLFAX): BUSINESS OVERVIEW
    • FIGURE 38 ENOVIS CORPORATION: COMPANY SNAPSHOT (2021)
    • 11.1.7 ZIMVIE INC. (SUBSIDIARY OF ZIMMER BIOMET)
    • TABLE 170 ZIMVIE INC.: BUSINESS OVERVIEW
    • FIGURE 39 ZIMVIE INC.: COMPANY SNAPSHOT (2021)
    • 11.1.8 ARTHREX, INC.
    • TABLE 171 ARTHREX, INC.: BUSINESS OVERVIEW
    • 11.1.9 TERUMO CORPORATION
    • TABLE 172 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
    • 11.1.10 OSSATEC BENELUX LTD.
    • TABLE 173 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
    • 11.1.11 ISTO BIOLOGICS
    • TABLE 174 ISTO BIOLOGICS: BUSINESS OVERVIEW
    • 11.1.12 EMBER THERAPEUTICS, INC.
    • TABLE 175 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
    • 11.1.13 REGEN LAB SA
    • TABLE 176 REGEN LAB SA: BUSINESS OVERVIEW
    • 11.1.14 ALTIS BIOLOGICS (PTY) LTD.
    • TABLE 177 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
    • 11.1.15 ITO CO., LTD.
    • TABLE 178 ITO CO., LTD.: BUSINESS OVERVIEW
  • 11.2 OTHER COMPANIES
    • 11.2.1 ELIZUR CORPORATION
    • 11.2.2 BTT HEALTH GMBH
    • 11.2.3 STIMULATE HEALTH
    • 11.2.4 VQ ORTHOCARE
    • 11.2.5 KINEX MEDICAL COMPANY, LLC
  • *Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS